hydroxychloroquine for COVID-19 - living meta-analysis of clinical studies

meta|evidence COVID-19

Living systematic review and meta-analysis

vs. potential COVID-19 treatments
vs. antiviral and associated therapy
vs. azithromycin
vs. control
vs. placebo
vs. standard of care
vs. Vitamins
vs. vitamin C

All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
root
secondary prevention

Studies
Mapping
Meta-analysis
Excluded 3

table network network 2

display ongoing demontrated benefit only

popup

Agusti, 2020

hydroxychloroquine vs. control

COVID 19 outpatients

Reis (Hydroxychloroquine) (TOGETHER), 2021 NCT04403100

hydroxychloroquine vs. placebo

COVID 19 outpatients

COPE – Coalition V, 2022 NCT04466540

hydroxychloroquine vs. placebo

COVID 19 outpatients

COMIHY, 2020 NCT04340544

hydroxychloroquine vs. placebo

COVID 19 outpatients

Q-PROTECT -HCQ alone, 2020 NCT04349592

hydroxychloroquine vs. placebo

COVID 19 outpatients

COVID-PEP Severity (Skipper), 2020 NCT04308668

hydroxychloroquine vs. placebo

COVID 19 outpatients

BCN PEP-CoV-2-Study 2 (Mitja et al. Clin Infect Dis), 2020 NCT04304053

hydroxychloroquine vs. standard of care

COVID 19 outpatients

BCN PEP-CoV-2-Study 2 (Mitja Lancet-preprint), 2020 NCT04304053

hydroxychloroquine vs. standard of care

COVID 19 outpatients

Kanran M, 2020 NCT04491994

hydroxychloroquine vs. standard of care

COVID 19 outpatients

NCT04597775, 0 NCT04597775

hydroxychloroquine vs. standard of care

COVID 19 outpatients

PATCH Cohort 1 (Amaravadi), 2021 NCT04329923

hydroxychloroquine vs. standard of care

COVID 19 outpatients

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -

Extraction panel open

An extraction panel is open